Eduard Preis

Mr. Eduard Preis

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Sherif Ashraf FahmySherif Ashraf Fahmy
Sherif Ashraf Fahmy
Eduard PreisEduard Preis
Eduard Preis
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Hassan AzzazyHassan Azzazy
Hassan Azzazy
Platinum nanoparticles (PtNPs) have superior physicochemical properties and great potential in biomedical applications. Eco-friendly and economic approaches for the synthesis of PtNPs have been developed to overcome the shortcomings of the traditional physical and chemical methods. Various biogenic entities have been utilized in the green synthesis of PtNPs, including mainly plant extracts, algae, fungi bacteria, and their biomedical effects were assessed. Other biological derivatives have been used in the synthesis of PtNPs such as egg yolk, sheep milk, honey, and bovine serum albumin protein. The green approaches for the synthesis of PtNPs have reduced the reaction time, the energy required, and offered ambient conditions of fabrication. This review highlights the state-of-the-art methods used for green synthesis of PtNPs, synthesis parameters, and their reported biomedical applications.

19 August 2020 in Materials
Verified
Journal Article
Open access
PDF file
Sherif Ashraf FahmySherif Ashraf Fahmy
Sherif Ashraf Fahmy
Eduard PreisEduard Preis
Eduard Preis
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Hassan AzzazyHassan Azzazy
Hassan Azzazy
Palladium nanoparticles (Pd NPs) showed great potential in biomedical applications because of their unique physicochemical properties. Various conventional physical and chemical methods have been used for the synthesis of Pd NPs. However, these methods include the use of hazardous reagents and reaction conditions, which may be toxic to health and to the environment. Thus, eco-friendly, rapid, and economic approaches for the synthesis of Pd NPs have been developed. Bacteria, fungi, yeast, seaweeds, plants, and plant extracts were used to prepare Pd NPs. This review highlights the most recent studies for the biosynthesis of Pd NPs, factors controlling their synthesis, and their potential biomedical applications.

19 November 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JGJulia Gross-Rother
Julia Gross-Rother
MBMichaela Blech
Michaela Blech
Eduard PreisEduard Preis
Eduard Preis
Udo BakowskyUdo Bakowsky
Udo Bakowsky
PGPatrick Garidel
Patrick Garidel
Detection and characterization of particles in the visible and subvisible size range is critical in many fields of industrial research. Commercial particle analysis systems have proliferated over the last decade. Despite that growth, most systems continue to be based on well-established principles, and only a handful of new approaches have emerged. Identifying the right particle-analysis approach remains a challenge in research and development. The choice depends on each individual application, the sample, and the information the operator needs to obtain. In biopharmaceutical applications, particle analysis decisions must take product safety, product quality, and regulatory requirements into account. Biopharmaceutical process samples and formulations are dynamic, polydisperse, and very susceptible to chemical and physical degradation: improperly handled product can degrade, becoming inactive or in specific cases immunogenic. This article reviews current methods for detecting, analyzing, and characterizing particles in the biopharmaceutical context. The first part of our article represents an overview about current particle detection and characterization principles, which are in part the base of the emerging techniques. It is very important to understand the measuring principle, in order to be adequately able to judge the outcome of the used assay. Typical principles used in all application fields, including particle–light interactions, the Coulter principle, suspended microchannel resonators, sedimentation processes, and further separation principles, are summarized to illustrate their potentials and limitations considering the investigated samples. In the second part, we describe potential technical approaches for biopharmaceutical particle analysis as some promising techniques, such as nanoparticle tracking analysis (NTA), micro flow imaging (MFI), tunable resistive pulse sensing (TRPS), flow cytometry, and the space- and time-resolved extinction profile (STEP®) technology.

28 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
Ahmed SomaidaAhmed Somaida
Ahmed Somaida
AAAbdallah Mohamed Ayoub
Abdallah Mohamed Ayoub
FAFahd M. Alsharif
Fahd M. Alsharif
Eduard PreisEduard Preis
Eduard Preis
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Plant-derived proteins have emerged as leading candidates in several drug and food delivery applications in diverse pharmaceutical designs. Zein is considered one of the primary plant proteins obtained from maize, and is well known for its biocompatibility and safety in biomedical fields. The ability of zein to carry various pharmaceutically active substances (PAS) position it as a valuable contender for several in vitro and in vivo applications. The unique structure and possibility of surface covering with distinct coating shells or even surface chemical modifications have enabled zein utilization in active targeted and site-specific drug delivery. This work summarizes up-to-date studies on zein formulation technology based on its structural features. Additionally, the multiple applications of zein, including drug delivery, cellular imaging, and tissue engineering, are discussed with a focus on zein-based active targeted delivery systems and antigenic response to its potential in vivo applicability.

5 July 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
ADAlice Abu Dayyih
Alice Abu Dayyih
BGBernd Gutberlet
Bernd Gutberlet
Eduard PreisEduard Preis
Eduard Preis
KEKonrad H. Engelhardt
Konrad H. Engelhardt
MAMuhammad Umair Amin
Muhammad Umair Amin
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Antimicrobial strategies with high efficacy against bacterial infections are urgently needed. The development of effective therapies to control bacterial infections is still a challenge. Herein, near-infrared (NIR)-activated thermosensitive liposomes (TSL) were loaded with the NIR-dye 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR) and the water-soluble hypericin (Hyp) β-cyclodextrin inclusion complex (Hyp-βCD). DiR and Hyp-βCD loaded thermosensitive liposomes (DHβCD-TSL) are functionalized for photothermal triggered release and synergistic photodynamic therapy to eliminate the gram-positive Staphylococcus saprophyticus. The dually active liposomes allow the production of heat and singlet oxygen species with the help of DiR and Hyp, respectively. The elevated temperature, generated by the NIR irradiation, irreversibly damages the bacterial membrane, increases the permeation, and melts the liposomes via a phase-transition mechanism, which allows the release of the Hyp-βCD complex. The photodynamic effect of Hyp-βCD eradicates the bacterial cells owing to its toxic oxygen species production. DHβCD-TSL measured the size of 130 nm with an adequate encapsulation efficiency of 81.3% of Hyp-βCD. They exhibited a phase transition temperature of 42.3 °C, while they remained stable at 37 °C, and 44% of Hyp-βCD was released after NIR irradiation (T > 47 °C). The bacterial viability dropped significantly after the synergistic treatment (>4 log10), indicating that the NIR-activated TSL have immense therapeutic potential to enhance the antibacterial efficacy. The liposomes showed good biocompatibility, which was confirmed by the cellular viability of mouse fibroblasts (L929).

1 September 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Eduard PreisEduard Preis
Eduard Preis
EBElias Baghdan
Elias Baghdan
MAMichael Agel
Michael Agel
TAThomas Anders
Thomas Anders
MPMarcel Pourasghar
Marcel Pourasghar
Udo BakowskyUdo Bakowsky
Udo Bakowsky